These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

436 related items for PubMed ID: 12286999

  • 1. Ask the experts: progestin-only contraceptives.
    Hatcher RA, Schnare S.
    Contracept Technol Update; 1993 Jul; 14(7):114-5. PubMed ID: 12286999
    [Abstract] [Full Text] [Related]

  • 2. Metabolic parameter, bleeding, and weight changes in U.S. women using progestin only contraceptives.
    Mainwaring R, Hales HA, Stevenson K, Hatasaka HH, Poulson AM, Jones KP, Peterson CM.
    Contraception; 1995 Mar; 51(3):149-53. PubMed ID: 7621683
    [Abstract] [Full Text] [Related]

  • 3. A comparison of levonorgestrel implants with depo-medroxyprogesterone acetate injections for contraception.
    London RS.
    J SOGC; 1993 Oct; 15(8):925-8, 32. PubMed ID: 12318530
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Depo-Provera and Norplant implants prove no competition for no. 1 choice, OCs. The 1994 pill survey.
    American Health Consultants.
    Contracept Technol Update; 1994 Dec; 15(12):157-61. PubMed ID: 12288903
    [Abstract] [Full Text] [Related]

  • 9. A prospective study of adolescents who choose among levonorgestrel implant (Norplant), medroxyprogesterone acetate (Depo-Provera), or the combined oral contraceptive pill as contraception.
    Cromer BA, Smith RD, Blair JM, Dwyer J, Brown RT.
    Pediatrics; 1994 Nov; 94(5):687-94. PubMed ID: 7936897
    [Abstract] [Full Text] [Related]

  • 10. A prospective comparison of bone density in adolescent girls receiving depot medroxyprogesterone acetate (Depo-Provera), levonorgestrel (Norplant), or oral contraceptives.
    Cromer BA, Blair JM, Mahan JD, Zibners L, Naumovski Z.
    J Pediatr; 1996 Nov; 129(5):671-6. PubMed ID: 8917232
    [Abstract] [Full Text] [Related]

  • 11. Not FDA-approved, but experts recommend Depo-Provera.
    Contracept Technol Update; 1992 Jan; 13(1):1-7. PubMed ID: 12343458
    [Abstract] [Full Text] [Related]

  • 12. FDA advisory panel recommends approval for Depo-Provera.
    Contracept Technol Update; 1992 Oct; 13(10):159-60. PubMed ID: 12344726
    [Abstract] [Full Text] [Related]

  • 13. Medicolegal issues surrounding Depo-Provera easily overcome.
    Contracept Technol Update; 1992 Jan; 13(1):16, 18. PubMed ID: 12343460
    [Abstract] [Full Text] [Related]

  • 14. Depo-Provera: just another contraceptive?
    Jones M.
    Fertil Contracept; 1978 Apr; 2(2):26-9. PubMed ID: 12336094
    [Abstract] [Full Text] [Related]

  • 15. [Prolonged use of medroxyprogesterone acetate for contraception].
    Pena Delgado J, Aleman Herrera M, Baez Reyes A.
    Sem Med Mex; 1981 Jun 26; 98(11):331-50. PubMed ID: 12279435
    [Abstract] [Full Text] [Related]

  • 16. Use multiple strategies to manage common pill side effects.
    Contracept Technol Update; 1988 Jul 26; 9(7):77-81. PubMed ID: 12281576
    [Abstract] [Full Text] [Related]

  • 17. Depo Provera: still controversial.
    Wren LM.
    Int Health News; 1988 Feb 26; 9(2):2-3, 8. PubMed ID: 12179873
    [Abstract] [Full Text] [Related]

  • 18. Researcher explains status of Depo Provera. [Answer to question of Marienetta Blackwell].
    Greenspan A.
    Contracept Technol Update; 1981 Mar 26; 2(3):35-6. PubMed ID: 12337540
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. FDA board investigates Depo-Provera safety.
    Contracept Technol Update; 1983 Mar 26; 4(3):25-7. PubMed ID: 12266161
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 22.